Pharmaceutical industry – Page 24
-
BusinessWhat might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
-
OpinionDivergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
-
OpinionIn search of ultimate selectivity
A catalyst that reacts only with aryl iodides, spurning bromides and chlorides
-
NewsBig costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
BusinessUK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
BusinessBattling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
OpinionWhat are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
ArticleStrength through diversity
Why people should be at the heart of a forward-thinking contract research organisation
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
-
OpinionHow science shapes our psychology
We learn to embrace the unexpected, follow evidence over opinion and accept that most experiments fail
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessSartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes